ArticleJournal of Korean medical science2013

Transglutaminase 2 expression predicts progression free survival in non-small cell lung cancer patients treated with epidermal growth factor receptor tyrosine kinase inhibitor.

Jae-Heon Jeong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.